Investigating the effects of physiological bile acids on GLP-1 secretion and glucose tolerance in normal and GLP-1R(-/-) mice. (Q50522015)

14 March 2018

title

Investigating the effects of physiological bile acids on GLP-1 secretion and glucose tolerance in normal and GLP-1R(-/-) mice. (English)

1 reference

14 March 2018

author name string

Eamon P Rafferty

1

1 reference

14 March 2018

Alastair R Wylie

2

1 reference

14 March 2018

Katharine H Hand

3

1 reference

14 March 2018

Chris E Elliott

4

1 reference

14 March 2018

David J Grieve

5

1 reference

14 March 2018

Brian D Green

6

1 reference

14 March 2018

publication date

27 April 2011

1 reference

14 March 2018

published in

Biological Chemistry

1 reference

14 March 2018

volume

392

1 reference

14 March 2018

issue

6

1 reference

14 March 2018

page(s)

539-546

1 reference

14 March 2018

Glucagon-like peptide-1 receptor knockout mice are protected from high-fat diet-induced insulin resistance

cites work

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Biology of incretins: GLP-1 and GIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

The incretin concept today

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Recent advances in antidiabetic drug therapies targeting the enteroinsular axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Direct induction of CCK and GLP‐1 release from murine endocrine cells by intact dietary proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Incretin hormone mimetics and analogues in diabetes therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Chronic treatment with exendin(9-39)amide indicates a minor role for endogenous glucagon-like peptide-1 in metabolic abnormalities of obesity-related diabetes in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Bile acids enhance the activity of the insulin receptor and glycogen synthase in primary rodent hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Acute and chronic effects of dietary fatty acids on cholecystokinin expression, storage and secretion in enteroendocrine STC-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Biological activity and antidiabetic potential of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide, GIP(1-16) and (Pro3)GIP(1-16).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Insulin-releasing and metabolic effects of small molecule GLP-1 receptor agonist 6,7-dichloro-2-methylsulfonyl-3-N-tert-butylaminoquinoxaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

A G protein-coupled receptor responsive to bile acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Farnesoid X receptor is essential for normal glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Identification of a nuclear receptor for bile acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Identification of membrane-type receptor for bile acids (M-BAR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Metabolic effects of sub-chronic ablation of the incretin receptors by daily administration of (Pro3)GIP and exendin(9-39)amide in obese diabetic (ob/ob) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Bile acids: natural ligands for an orphan nuclear receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Luminal glucagon-like peptide-1(7–36) amide-releasing factors in the isolated vascularly perfused rat colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Novel insulin/GIP co-producing cell lines provide unexpected insights into Gut K-cell function in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

The enzymes, regulation, and genetics of bile acid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Targeting bile-acid signalling for metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

TGR5-mediated bile acid sensing controls glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Bile acids have the gall to function as hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Endogenous bile acids are ligands for the nuclear receptor FXR/BAR

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.050

21 January 2018

Identifiers

DOI

10.1515/BC.2011.050

1 reference

14 March 2018

1 reference

14 March 2018